just saw quince therapeutics up like 57% in premarket lol. apparently they're shopping around for strategic alternatives - partnerships, M&A, licensing deals, whatever maximizes shareholder value. hired LifeSci Capital to run the process. stock was trading at $0.13 yesterday and jumped to $0.20 this morning. wild swings for a biotech play. over the past year it's been bouncing between $0.12 and $4.55 so this is pretty typical volatility for them. board said they won't say anything else unless they actually close a deal. interesting to watch how this plays out

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned